Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06471582

Timing of Energy Availability on Menstrual Cycle Function

Implications for the Timing of Energy Availability on Menstrual Cycle Function

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
University of Colorado, Colorado Springs · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The primary aim of this clinical trial is to evaluate how fasted prolonged exercise may influence circulating reproductive hormones (i.e., estradiol, progesterone, luteinizing hormone) and menstrual cycle length when energy availability is maintained at or above 30 kcal/kg lean body mass/ day among women who regularly do running or cycling exercise. A secondary aim is to determine the effects of fasted prolonged exercise on serum leptin and cortisol. Participants will be asked to do the following over a \~3 month enrollment period: * attend a laboratory visit at the beginning of the study to have their resting metabolic rate, aerobic fitness, and body composition tested * monitor their menstrual cycle length, urine hormones, perceived stress levels, and diet for \~3 months * complete 3, 90-minute exercise sessions on a stationary bike or treadmill either fed (consuming a carbohydrate meal 1 h prior and 0.7 g carbohydrate/ kg body mass/ h during exercise) or fasted (consuming no meal prior and no carbohydrates during exercise) during month \~3 * saliva samples will be taken prior to and after 90-minute exercise sessions for quantification of leptin and cortisol

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTArtificially Sweetened Carbohydrate BeverageBeverage containing 0.7 g carbohydrate/ kg body mass/ h as a 2:1 mixture of glucose and fructose and artificial sweetener
DIETARY_SUPPLEMENTArtificially Sweetened BeverageBeverage containing no carbohydrates or kilocalories and an artificial sweetener

Timeline

Start date
2024-08-01
Primary completion
2027-08-31
Completion
2027-08-31
First posted
2024-06-24
Last updated
2025-01-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06471582. Inclusion in this directory is not an endorsement.